Article
The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Transfusion - 1 Nov 2008
Müller Sina P, Bartels Iris, Stein Werner, Emons Günther, Gutensohn Kai, Köhler Michael, Legler Tobias J
Abstract excerpt
BACKGROUND: Noninvasive fetal RHD genotyping might become a valuable tool in decision making on antenatal Rh prophylaxis, which is currently in routine practice for all D- pregnancies in several countries. This study provides a large-scale validation study of this technology to address questions concerning feasibility and applicability of its introduction into clinical routine. STUDY DESIGN AND METHODS: Real-time...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
